|
Volumn 21, Issue 10, 2015, Pages 2201-2203
|
A new B7:CD28 family checkpoint target for cancer immunotherapy: HHLA2
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD28 ANTIGEN;
GAMMA INTERFERON;
PROGRAMMED DEATH 1 LIGAND 1;
PROTEIN KINASE B;
RETROVIRUS H LONG TERMINAL REPEAT ASSOCIATING PROTEIN 2;
TRANSMEMBRANE AND IMMUNOGLOBULIN DOMAIN CONTAINING 2;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
VIRUS PROTEIN;
IMMUNOGLOBULIN;
ANTIGEN PRESENTING CELL;
ARTICLE;
BINDING AFFINITY;
CANCER IMMUNOTHERAPY;
CELL FUNCTION;
CELL PROLIFERATION;
HUMAN;
IMMUNE EVASION;
NATURAL KILLER CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN LOCALIZATION;
PROTEIN PHOSPHORYLATION;
PROTEIN TARGETING;
PROTEIN TRANSPORT;
T LYMPHOCYTE;
TUMOR IMMUNITY;
UPREGULATION;
ANIMAL;
FEMALE;
METABOLISM;
TRIPLE NEGATIVE BREAST CANCER;
ANIMALS;
FEMALE;
HUMANS;
IMMUNOGLOBULINS;
TRIPLE NEGATIVE BREAST NEOPLASMS;
|
EID: 84942124413
PISSN: 10780432
EISSN: 15573265
Source Type: Journal
DOI: 10.1158/1078-0432.CCR-14-2658 Document Type: Article |
Times cited : (46)
|
References (9)
|